Cipla
to invest Rs 1000 crore in UK
Cipla Ltd, in
collaboration with the UK government, has expressed its intention to make
investments of up to GBP 100 million (about Rs 1028 crore) in its UK subsidiary
over the next few years. The investments are expected to facilitate the launch
of a range of products in the area of respiratory, oncology and antiretroviral
medicines to further Cipla’s higher purpose of ‘universal affordable access’.
Cipla also plans to invest
in R&D activities, clinical trials and expand further internationally. “The
investment underscores the growing importance of UK in Cipla’s long term
strategy,” said the company in a BSE filing.
Cipla has been fortifying
its global base in last couple of years. Last month itself, in a two separate
deals, Cipla acquired majority stakes in a Yemeni and a Sri Lankan company. In
2013, it had acquired Quality Chemical Industries (Uganda), Celeris (Croatia)
and Medpro (South Africa).
No comments:
Post a Comment